Detalhe da pesquisa
1.
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
Breast Cancer Res Treat
; 199(2): 243-252, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36944848
2.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31157962
3.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 379(2): 111-121, 2018 Jul 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29860917
4.
Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth.
Genome Res
; 2018 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29326299
5.
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 22(1): 9, 2020 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31969184
6.
Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy.
Int J Cancer
; 146(7): 1851-1861, 2020 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31603993
7.
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.
Br J Cancer
; 123(12): 1720-1729, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32963347
8.
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Lancet
; 394(10215): 2155-2164, 2019 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31813636
9.
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
BMC Cancer
; 20(1): 316, 2020 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32293356
10.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(1): 88-99, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30509771
11.
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 21(1): 133, 2019 12 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31796073
12.
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
N Engl J Med
; 374(3): 211-22, 2016 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-26789870
13.
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.
Gastroenterology
; 155(3): 799-814.e13, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29775598
14.
AIRVF: a filtering toolbox for precise variant calling in Ion Torrent sequencing.
Bioinformatics
; 34(7): 1232-1234, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29126106
15.
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology).
Br J Cancer
; 118(5): 629-633, 2018 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29241223
16.
Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer.
Br J Cancer
; 119(11): 1347-1357, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30420612
17.
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
Pharmacogenet Genomics
; 28(6): 147-152, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29768301
18.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 373(21): 2005-14, 2015 Nov 19.
Artigo
Inglês
| MEDLINE | ID: mdl-26412349
19.
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Breast Cancer Res Treat
; 168(1): 69-77, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29128898
20.
Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.
Breast Cancer Res Treat
; 163(2): 255-262, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28243895